Stay updated with breaking news from Damien Mcdevitt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Will Fund Clinical Trials of Company's First iPSC-derived Autologous Dopamine Neuron Replacement for Parkinson's DiseaseSAN DIEGO, May 9, 2022 /PR...
Aspen Neuroscience, Inc. announced that this month it will launch the first patient screening study of its kind, working with multiple clinical screening
/PRNewswire/ -- Aspen Neuroscience, Inc., a private biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies, including the...
Aspen Neuroscience, a private biotechnology company developing the first autologous neuron replacement therapies to treat Parkinson's disease (PD), announced today that Andres Bratt-Leal, PhD, has been promoted to Senior Vice President of Research & Development.